Femoral osteomyelitis due to Cladophialophora arxii in a patient with chronic granulomatous disease

Infection

Volumn 37, Issue 5, 2009, Pages 469-473

  Shigemura, T ^a   Agematsu, K ^a   Yamazaki, T ^a   Eriko, K ^a   Yasuda, G ^a   Nishimura, K ^b   Koike, K ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; COTRIMOXAZOLE; FLUCONAZOLE; FLUCYTOSINE; GAMMA INTERFERON; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; MICAFUNGIN; MICONAZOLE; VORICONAZOLE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CLADOPHIALOPHORA ARXII; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DRUG BLOOD LEVEL; FEMUR; FUNGUS; HUMAN; INFECTION; INFECTION PREVENTION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOMYELITIS; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; ASCOMYCOTA; DEBRIDEMENT; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; FEMUR; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; ITRACONAZOLE; MALE; MYCOSES; OSTEOMYELITIS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 70350183775     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-009-8238-9     Document Type: Article

References (19)

1. B.H. Segal T.L. Leto J.I. Gallin H.L. Malech S.M. Holland 2000 Genetic, biochemical, and clinical features of chronic granulomatous disease Medicine (Baltimore) 79 170 200 10.1097/00005792-200005000-00004 1:CAS:528: DC%2BD3cXktFGjt7s%3D (Pubitemid 30327531)
2. J.A. Winkelstein M.C. Marino R.B. Johnston Jr J. Boyle J. Curnutte J.I. Gallin H.L. Malech S.M. Holland H. Ochs P. Quie R.H. Buckley C.B. Foster S.J. Chanock H. Dickler 2000 Chronic granulomatous disease. Report on a national registry of 368 patients Medicine (Baltimore) 79 155 169 10.1097/00005792- 200005000-00003 1:STN:280:DC%2BD3czgtlemtg%3D%3D (Pubitemid 30327530)
3. M.A. Pfaller S. Arikan M. Lozano-Chiu Y. Chen S. Coffman S.A. Messer R. Rennie C. Sand T. Heffner J.H. Rex J. Wang N. Yamane 1998 Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing J Clin Microbiol 36 2609 2612 1:CAS:528:DyaK1cXlvVehtrw%3D 9705401
4. M.S. Cohen R.E. Isturiz H.L. Malech R.K. Root C.M. Wilfert L. Gutman R.H. Buckley 1981 Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi Am J Med 71 59 66 10.1016/0002- 9343(81)90259-X 1:STN:280:DyaL3M3ivFGmtw%3D%3D 7195647
5. P.D. Sponseller H.L. Malech E.F. McCarthy Jr S.F. Horowitz G. Jaffe J.I. Gallin 1991 Skeletal involvement in children who have chronic granulomatous disease J Bone Joint Surg Am 73 37 51 1:STN:280:DyaK3M%2FptlehsQ%3D%3D 1985993
6. K. Tintelnot P. von Hunnius G.S. de Hoog A. Polak-Wyss E. Gueho F. Masclaux 1995 Systemic mycosis caused by a new Cladophialophora species J Med Vet Mycol 33 349 354 10.1080/02681219580000671 1:STN:280:DyaK287it1Cquw%3D%3D 8544088
7. S.G. Revankar D.A. Sutton M.G. Rinaldi 2004 Primary central nervous system phaeohyphomycosis: a review of 101 cases Clin Infect Dis 38 206 216 10.1086/380635 14699452 (Pubitemid 38113028)
8. J.M. Ziza B. Dupont A. Boissonnas O. Meyniard J. Bedrossian E. Drouhet G. Cremer 1985 Osteoarthritis caused by dematiaceous fungi. Apropos of 3 cases Ann Med Interne (Paris) 136 393 397 1:STN:280:DyaL28%2FkvFSntw%3D%3D
9. P.J. Gavin D.A. Sutton B.Z. Katz 2002 Fatal endocarditis in a neonate caused by the dematiaceous fungus Phialemonium obovatum: case report and review of the literature J Clin Microbiol 40 2207 2212 10.1128/JCM.40.6.2207-2212.2002 12037088 (Pubitemid 34596408)
10. N.L. Sharma V. Mahajan R.C. Sharma A. Sharma 2002 Subcutaneous pheohyphomycosis in India - a case report and review Int J Dermatol 41 16 20 10.1046/j.1365-4362.2002.01337.x 11895508 (Pubitemid 34192969)
11. M.S. Gonzalez B. Alfonso D. Seckinger A.A. Padhye L. Ajello 1984 Subcutaneous phaeohyphomycosis caused by Cladosporium devriesii, sp. nov. Sabouraudia 22 427 432 1:STN:280:DyaL2M%2Fms1Wqtg%3D%3D 6505915
12. D.M. Mitchell M. Fitz-Henley J. Horner-Bryce 1990 A case of disseminated phaeohyphomycosis caused by Cladosporium devriesii West Indian Med J 39 118 123 1:STN:280:DyaK3czosFOiuw%3D%3D 2402896
13. R.A. Seger 2008 Modern management of chronic granulomatous disease Br J Haematol 140 255 266 10.1111/j.1365-2141.2007.06880.x 1:CAS:528: DC%2BD1cXitlaktrs%3D 18217895
14. J. Dotis E. Roilides 2004 Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus Int J Infect Dis 8 103 110 10.1016/j.ijid.2003.06.001 14732328 (Pubitemid 38166076)
15. G.P. Bodey 1992 Azole antifungal agents Clin Infect Dis 14 S161 S169 1314105
16. J.I. Gallin D.W. Alling H.L. Malech R. Wesley D. Koziol B. Marciano E.M. Eisenstein M.L. Turner E.S. DeCarlo J.M. Starling S.M. Holland 2003 Itraconazole to prevent fungal infections in chronic granulomatous disease N Engl J Med 348 2416 2422 10.1056/NEJMoa021931 1:CAS:528:DC%2BD3sXksFKgur8%3D 12802027 (Pubitemid 36682820)
17. J.M. Poirier G. Cheymol 1998 Optimisation of itraconazole therapy using target drug concentrations Clin Pharmacokinet 35 461 473 10.2165/00003088- 199835060-00004 1:CAS:528:DyaK1MXmsVagtA%3D%3D 9884817 (Pubitemid 29010176)
18. J.H. Rex M.A. Pfaller T.J. Walsh V. Chaturvedi A. Espinel-Ingroff M.A. Ghannoum L.L. Gosey F.C. Odds M.G. Rinaldi D.J. Sheehan D.W. Warnock 2001 Antifungal susceptibility testing: practical aspects and current challenges Clin Microbiol Rev 14 643 658 10.1128/CMR.14.4.643-658.2001 1:CAS:528: DC%2BD3MXot1Wms74%3D 11585779 (Pubitemid 32979625)
19. G.G. Zhanel D.G. Saunders D.J. Hoban J.A. Karlowsky 2001 Influence of human serum on antifungal pharmacodynamics with Candida albicans Antimicrob Agents Chemother 45 2018 2022 10.1128/AAC.45.7.2018-2022.2001 1:CAS:528:DC%2BD3MXks1GksrY%3D 11408217 (Pubitemid 32591692)